Building sustainable production

Our goal is to make it possible for any country in the world or pharmaceutical company to afford and establish a reliable medical isotopes supply chain. Colibri’s focus is on making production commercially independent, economically effective and scalable on demand.

Technology and capacity

The commercialization of spin-off technologies for Lu-177 n.c.a. and Ac-225 is underway as Colibri establishes production capacities in multiple countries. Lu-177 production under GMP marks the starting point for a broader development pipeline that also includes Ac-225, Tb-161 and Pb-212.

Global logistics

Fast and reliable global isotope supply is central to Colibri’s operations. Our extensive logistics network connects production sites with customers across the Americas, Europe, India, China and Africa. By coordinating complex, time-sensitive international deliveries, we help maintain a stable flow of isotopes and get products to customers on schedule.